News und Analysen
Bloomin’ Brands could blossom in 2024
Bloomin’ Brands (NASDAQ: BLMN) served mixed results for Q4 and provided tepid guidance, but repositioning efforts have the restaurant stock set up to blossom in 2024. A massive closure effort
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. 415% Biotech Hot Stock nach 15.973% mit BioNTech
23.02.24 08:03
London (www.aktiencheck.de , Anzeige)
Keurig-Dr Pepper stock: Time to take another sip?
Keurig Dr Pepper's (NASDAQ: KDP) share price fell following the Q4 results and guidance for 2024, setting up the next buying opportunity. The market is down but aligning with a bottoming pattern
Rivian shares gets discounted; shares can move lower
Rivian’s (NASDAQ: RIVN) Q4 release further proves that the EV market bubble has burst. Internal metrics and guidance suggest demand has peaked and current capacity is too much. The takeaway is
Top-Rated AMD nears major breakout level
While shares of Advanced Micro Devices (NASDAQ: AMD) might not grab the headlines as much as its competitor, Nvidia (NASDAQ: NVDA), shareholders of the global semiconductor company are undoubtedly
AI powerhouse NVIDIA will hit $1000 soon
Traders and investors fearing an NVIDIA (NASDAQ: NVDA)-led market correction can put those fears to rest. The company’s Q4 results reveal that the AI market is still strong, stronger than expected
How to use iron condors to collect income from stock options
Achieving risk-free passive income from the stock market is the dream of investors. Unfortunately, nothing in the stock market are risk-free. However, if you are willing to have a cap on your
Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. 400% Biotech Aktientip nach 9.290% mit Novo-Nordisk
22.02.24
London (www.aktiencheck.de, Anzeige)
3 Reasons the Capital One-Discover merger is a big deal
What’s in your wallet? In the not-so-distant future, it might be a card issued by the combined entity of Capital One Financial Corp. (NYSE: COF) and Discover Financial Services (NYSE: DFS).
Spotify sounding better to analysts as company tunes into profits
Spotify Technology S.A. (NYSE: SPOT) is trading at its best levels since December 2021 on the strength of hardy revenue growth and a return to profitability.
Spotify is a global music streaming
Informatica charges ahead on AI-driven data management tailwinds
Informatica Inc. (NASDAQ: INFA) offers its artificial intelligence (AI) platform for enterprises to unify and manage their data to unlock transformative outcomes. The computer and technology
Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 15973% mit BioNTech
21.02.24
London (www.aktiencheck.de, Anzeige)
Walmart’s uptrend is intact; buy it when it dips
Walmart (NYSE: WMT) is in an uptrend and will likely continue. The Q4 results and guidance for 2024 underpin an expectation for capital returns and improving shareholder value for this retail
These 5 stocks have unique competitive edge and room to run
A prominent investment theme of the past year is the outperformance of profitable companies with a unique competitive advantage.
Obvious examples of stocks in that category include Nvidia Corp.
Higher VIX just made Realty Income’s 6% dividend better
Patient investors look for safer stocks when the VIX begins to pop to protect their portfolio or expose themselves to high-quality assets at potential discounts. Realty Income (NYSE: O) could be
Warren Buffett goes ex-tech and pro-oil, sell Apple buy Chevron?
Every market brings you a cycle to take advantage of, that is for sure, and there will always be cycles to come. Warren Buffett has been quoted saying that timing the market can turn out to be a
Sensation: 100 mal wirksamer gegen Krebs - Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensation: 100 mal wirksamer gegen Krebs - Neuer 343% Biotech Hot Stock. Nach 15973% mit BioNTech und 134452% mit Biogen
20.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Best restaurant stocks to buy now
Sinking your teeth into a juicy burger from your favorite fast-food chain is comfort food at its finest. But as an investor, capitalizing on a flourishing restaurant empire may prove even more
Can UnitedHealth Group afford to keep Medicare Advantage plans?
Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit
Marathon Oil stock is the place to be if you need value
Not all stocks are created equal, and this year energy stocks could quickly become the market's favorite. A once-in-a-cycle opportunity to line up your portfolio with all the macro forces at play
Eilt: Krebsmedikament bis zu 100 mal wirksamer - Kursrallye voraus. Neuer 343% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Krebsmedikament bis zu 100 mal wirksamer - Kursrallye voraus. Neuer 343% Biotech Hot Stock nach 134452% mit Biogen
19.02.24
London (www.aktiencheck.de, Anzeige)
Cisco Systems stock: Income investors buy the dip
Cisco Systems (NASDAQ: CSCO) issued a decent FQ2 report but guided lower for Q3, leaving the market less than inspired. However cold the guide, someone is stepping into the buy the dip, and it
Arista Networks stock soars past big tech rival Cisco
Arista Networks Inc. (NYSE: ANET) may not be as well known among tech investors as Cisco (NASDAQ: CSCO), but it's outperformed its larger rival by a wide margin in the past year.
Arista posted
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 343% Biotech Aktientip nach 15.973%
16.02.24 08:03
London (www.aktiencheck.de , Anzeige)